AnJie Broad has abundant experiences in the sector of Life Sciences, Pharma & Healthcare. This sector in PRC market is of the features of stringent regulatory calibers, booming technology innovation trend, complicated commercial environment and diversified needs for legal and compliance services. We are providing legal services in all aspects covering the whole industry chain, while the types of our clients include hospital, medical institution, testing laboratory, CRO, CSO, CMO, innovative pharmaceutical and generic drugs enterprises, bio-pharmacy, biological products producer, traditional Chinese medicine producer, medical equipment/devices/consumables producer, medicine distributor, medical supply chain, mobile healthcare, internet hospital, medical intelligent hardware, Medical AI, digital therapy provider, synthetic biology enterprises, medical IT service providers, as well as the venture capital firm focusing on the healthcare and life science sector. In addition to assisting our client in completion of investment and financing deals, M&A, and license-in/out transactions, we are also engaged in helping our clients to improve compliance management level and enhance IP protection.

The major clients of AnJie Broad in this sector include 3D Medicines, Alnylam, Alpine Intelligent Medical, AstraZeneca, Best Covered, BETTA Pharmaceutical, Baiyunshan Pharmaceutical, Chiesi, CSTONE Pharmaceuticals, Edding Pharma, Elekta, Evaheart, Fosun Pharma, Hepalink, Herbalife, HYBIO Pharmaceutical, Jinxin Pharmaceutical, Johnson &Johnson, KW Chinese Medicine, LeiAo Science, Lepure, LYNK, Medtronic, Nu Skin Enterprises, PFM Medical, Pinging Health, PingAn-Shionogi, Beijing Pro-med Technology, Roche, Sanhome, Sanofi, SAUFLON, Shanghai Pharma, Shenzhen Pregene, Shukun Technology, Sino-Biocan, Sino-Pharma, Synaptic Medical, Vincent Medical, VISIRNA, WeDoctor, WEGO Group, WuXi AppTec, Yunnan Baiyao, Yaoshibang, Zion, Nanchuang Chemical and Life Science, Trendi Medical, and etc.

We could provide the following legal services within this sector:

• Technology transfer, license-in/out transaction

• Disputes settlement and rights protection of domestic and overseas patents, trademarks and business secrets

• FTO analysis

• Merger filing

• Antitrust investigation and Antitrust compliance

• Unfair competition report and disputes settlement

• FCPA and Anti-corruption compliance

• Network security, data compliance and personal information protection

• Digitalization marketing compliance

• Private Equity/Venture Capital, Merger & Acquisition

• Bio-pharm investment fund formation

• Capital market and IPO (including HKEx Chapter 18A listing)